Variant Synonymizer: Platform to identify mutations defined in different ways is available now!
Over 2,000 gene–disease validation summaries are now available—no login required!
The gene Urocortin (UCN; HGNC:12516) has been evaluated in the context of type 2 diabetes mellitus (MONDO:0005148). In a multi‑patient study of multigenerational diabetes, UCN was included in a targeted next‑generation sequencing panel screening 27 candidate genes in 55 family probands (PMID:28993341). Although several pathogenic variants were identified in other genes, no UCN‑specific variant was reported, limiting the direct genetic evidence linking UCN to the diabetic phenotype.
The genetic evidence remains limited, as the association is based solely on the inclusion of UCN in gene panels and the context of familial disease rather than on the detection of multiple unrelated probands or robust segregation data (PMID:28993341). Inheritance in these families is consistent with an autosomal dominant pattern, a common feature in many forms of monogenic diabetes, yet UCN itself lacks reported segregating variants in affected relatives (segregation count = 0).
Functional studies in related systems have explored UCN’s role in stress response pathways; specifically, investigations in cardiovascular tissue demonstrated altered expression and identified a novel splice variant in heart failure (PMID:27754786). However, these experiments were conducted in a cardiac context and do not directly support pathogenicity in diabetes. As such, functional evidence for UCN’s involvement in type 2 diabetes remains limited.
Overall, the clinical data for UCN in type 2 diabetes is currently classified as limited. The genetic assessment is weakened by the absence of UCN‑specific pathogenic variants and supportive segregation data, while functional experiments offer insight into UCN biology in other tissues but do not directly address diabetic mechanisms.
Additional studies focusing on UCN‐specific mutations, refined segregation analyses, and functional assays tailored to diabetic models are essential to better define the gene’s role. This additional evidence may raise the confidence in UCN as a meaningful contributor to the etiology of type 2 diabetes.
Key Take‑home: Although UCN is a physiologically plausible candidate in diabetes given its role in stress response pathways, its current association with type 2 diabetes mellitus is limited and requires further corroborative studies to support diagnostic and therapeutic decision‑making.
Gene–Disease AssociationLimitedAssociation based on inclusion in a multi‑gene panel with no UCN‑specific pathogenic variants or robust segregation data reported (PMID:28993341). Genetic EvidenceLimitedNo specific UCN variants were detected in the proband cohort, limiting genetic evidence to its presence in the screening panel (PMID:28993341). Functional EvidenceLimitedFunctional studies pertain to UCN’s role in cardiac tissue, which does not directly translate to type 2 diabetes pathophysiology (PMID:27754786). |